Wenxuan Wu
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
PD-1 Inhibits CD4+ TRM-Mediated cDC1 Mobilization via Suppressing JAML in Human NSCLC.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 28, 2025
JAML promotes the antitumor role of tumor-resident CD8+ T cells by facilitating their innate-like function in human lung cancer.
Journal: Cancer letters
Published: December 06, 2023
Inflammatory dendritic cells restrain CD11b+CD4+ CTLs via CD200R in human NSCLC.
Journal: Cell reports
Published: July 26, 2023
Efficacy of PD-1 Inhibitors in First-Line Treatment for Advanced Gastroesophageal Junction and Gastric Cancer by Subgroups: A Systematic Review and Meta-Analysis.
Journal: Chemotherapy
Published: March 13, 2023
Single-Cell Profiling of Tumor Immune Microenvironment Reveals Immune Irresponsiveness in Gastric Signet-Ring Cell Carcinoma.
Journal: Gastroenterology
Published: September 20, 2022
Ileo-ileal intussusception and gastrointestinal bleeding caused by incidental heterotopic pancreas: four case reports.
Journal: Annals of translational medicine
Published: March 12, 2021
Left-side vs. right-side hepatectomy for hilar cholangiocarcinoma: a meta-analysis.
Journal: World journal of surgical oncology
Published: December 30, 2020
ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway.
Journal: Cancer letters
Published: July 30, 2020
DNA Methylation of Cannabinoid Receptor Interacting Protein 1 Promotes Pathogenesis of Intrahepatic Cholangiocarcinoma Through Suppressing Parkin-Dependent Pyruvate Kinase M2 Ubiquitination.
Journal: Hepatology (Baltimore, Md.)
Published: December 10, 2019
Last Updated: 09/26/2026